Table 1 Comparison of clinical and pathological characteristics between two treatment types with intravesical bacillus Calmette–Guérin
ALL (n = 78) | Induction (n = 40) | Maintenance (n = 38) | P value | |
|---|---|---|---|---|
Age, years (IQR) | 72 (64–78) | 76 (67–79) | 76 (64–76) | 0.36 |
Sex (%) | ||||
Men Women | 61 (78.2) | 33 (82.5) | 28 (73.7) | 0.42 |
17 (21.8) | 7 (18.5) | 10 (26.3) | ||
pT stage (%) | ||||
pTa/1 | 60 (76.9) | 33 (82.5) | 27 (71.1) | 0.39 |
pTis | 18 (23.1) | 7 (18.5) | 11 (8.9) | |
Grade (%) | ||||
G1/2 G3 | 63 (83.3) | 35 (87.5) | 28 (73.7) | 0.16 |
15 (16.7) | 5 (12.5) | 10 (26.3) | ||
Tumor size (%) | ||||
< 1 cm ≥ 1 cm | 45 (57.7) | 25 (62.5) | 20 (52.7) | 0.49 |
33 (42.3) | 15 (37.5) | 18 (37.3) | ||
Number of tumors (%) | ||||
Single Multiple | 14 (17.9) | 8 (20.0) | 6 (15.8) | 0.77 |
64 (72.1) | 32 (80.0) | 32 (84.2) | ||
Follow-up, months (IQR) | 36.2 (18.2–55.7) | 35.2 (19.3–48.3) | 35.9 (17.0–58.4) | 0.25 |